Not one of them has a MAA approval except for Zolpimist in USA and Canada which both areas not covered by SUDA's license so how are they going to take off.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025